Kristian Dambrino
Psychiatric/Mental Health · Nashville, TNNPI 1851818348
Payments from drug & device makers
Across 829 payments — averaging $541.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$307K
- Axsome Therapeutics, Inc.$107K
- Alkermes, Inc.$18K
- E.r. Squibb & Sons, L.L.C.$5K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$5K
- Johnson & Johnson$2K
- plus $5K from 20 others
What the payments were for
- Consulting fees$53,74112%
- Speaking & faculty fees$335,72775%
- Travel & lodging$36,2238%
- Food & beverage$22,7145%
- Education$1720%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 349 | $306,763 |
| Axsome Therapeutics, Inc. | 168 | $106,953 |
| Alkermes, Inc. | 64 | $18,416 |
| E.r. Squibb & Sons, L.L.C. | 30 | $5,004 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 41 | $4,530 |
| Johnson & Johnson | 18 | $2,074 |
| AbbVie(2 entities) | 40 | $1,491 |
| Janssen Scientific Affairs, LLC | 6 | $839 |
| Otsuka America Pharmaceutical, Inc. | 24 | $554 |
| Teva Pharmaceuticals USA, Inc. | 15 | $509 |
| Indivior Inc. | 20 | $234 |
| Supernus Pharmaceuticals, Inc. | 8 | $143 |
| Sage Therapeutics, LLC | 1 | $123 |
| Sunovion Pharmaceuticals Inc. | 10 | $120 |
| Vanda Pharmaceuticals Inc. | 4 | $118 |
| Ironshore Pharmaceuticals Inc. | 5 | $111 |
| Novocure Inc. | 1 | $108 |
| Acadia Pharmaceuticals Inc | 2 | $103 |
| Corium, LLC | 6 | $95 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $94 |
| Lundbeck LLC | 2 | $42 |
| Bausch Health US, LLC | 2 | $40 |
| Eisai Inc. | 3 | $40 |
| Biogen | 2 | $37 |
| Neos Therapeutics, LP | 1 | $21 |
| Tris Pharma Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INGREZZA$300,984
- Auvelity$104,086
- LYBALVI$67,029
- CAPLYTA$3,481
- COBENFY$3,181
- SPRAVATO$2,713
- ARISTADA$1,777
- VRAYLAR$291
- Austedo XR$239
- Zurzuvae$123
- ABILIFY MAINTENA$121
- ARISTADA INITIO$116
- Optune$108
How this compares
$448,576 in reported general payments places this provider in the 95th percentile of 1,167 psychiatric/mental health providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lamotrigine | 20 | $142 |
| Sertraline Hcl | 30 | $128 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Nashville
- Lauren HansenNashville$263K
- Aaron JonesNashville$20K
- Kathleen McCoyNashville$12K
- Preeti SrivastavaNashville$11K
- Kersten WoodleeNashville$10K
- Ariel NewtonNashville$10K
- Robert McKeownNashville$10K
- Debra YorkNashville$9K
- Laura MelaroBolivar$682K
- Fay BembryJohnson City$449K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.